Navigation Links
Coloplast Selected By LifeScience Alley to Host Minnesota Medical Device Panel
Date:8/24/2011

MINNEAPOLIS, Aug. 24, 2011 /PRNewswire/ -- Coloplast Corp. has been selected by LifeScience Alley to host its industry panel discussion today. The event will bring together several local companies to focus on medical device innovation, the future of the Minnesota medical device industry and proposed changes to the regulatory environment.

As part of his continued commitment to a thriving Minnesota medical community, Sen. Al Franken will join the discussion. Participants will speak specifically with Franken about the role the legislature can play in maintaining appropriate policies that ensure quality devices are brought to market while making critical reforms that support the medical device industry as it continues to drive innovation.

"Coloplast is excited to host this important panel," said Claus Bjerre, Coloplast U.S. President Chronic Care. "We selected Minnesota as the home of Coloplast's North American headquarters because of the strong medical device industry, the world-class medical community and the rich pool of talented employees here. Discussions like the one being held today advance the local medical community's efforts to innovate and bring products and services to market that improve patient quality of life and support the medical professionals who care for those patients."

Following the discussion, Coloplast will host Franken and Dale Wahlstrom, CEO of LifeScience Alley, on a tour of Coloplast's facility. The site features a state-of-the-art research and development Innovation Center and surgeon education labs.

"We are proud of our Minneapolis headquarters facility because it was designed with our most important stakeholders in mind: customers and employees," said Ash Keswani, global director, Coloplast Female Pelvic Health. "Our on-site Innovation Center helps us provide smarter, more advanced products for our customers. We also designed a work environment that employees are proud to come to each day and which the local talent pool finds attractive."

The panel, which is a closed discussion, will convene at Coloplast's North American headquarters at 1601 West River Road in Minneapolis. Minnesota companies participating in Wednesday's discussion include:

Affinity Capital Management
Apnex Medical
Berman Medical
Coloplast
ev3
Galil Medical
LifeScience Alley
Medtronic
Minnetronix
Smiths Medical
Spineology, Inc.
Tornier
U of M Law & Baker & Daniels
Vascular Solutions
Vital Images

About Coloplast

Danish medical device company Coloplast develops products and services that make life easier for people with very personal and private medical conditions. Working closely with the people who use our products, we create solutions that are sensitive to their special needs. We call this intimate healthcare. Our business includes ostomy care, urology, continence care, and wound and skin care. We operate globally and employ more than 7,000 people worldwide. In 2009, Coloplast opened the new North American headquarters in Minneapolis, Minnesota. The campus is LEED-certified (Leadership in Energy and Environmental Design) and is home to one of the company's three global research-and-development Innovation Centers. Others are located in Denmark and France.

To learn more about Coloplast, visit www.coloplast.com.

Coloplast develops products and services that make life easier for people with very personal and private medical conditions. Working closely with the people who use our products, we create solutions that are sensitive to their special needs. We call this intimate healthcare. Our business includes ostomy care, urology and continence care and wound and skin care. We operate globally and employ more than 7,000 people.

Coloplast develops, manufactures and markets medical devices and services to an increasing number of users all over the world.  Our business areas include ostomy products; urology & continence care products and products for wound & skin care.  We work closely with health care professionals and product users in creating new and innovative products and services.  We employ approximately 7,000 people.


'/>"/>
SOURCE Coloplast Corp.
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. BioSurplus Selected to Auction $10 Million in Lab Equipment
2. Linet Multicare® Hospital Bed Selected to Participate in National Program Highlighting Commitment to Healthcare Performance Improvement, Innovation
3. Dr. Jay Yadav, CardioMEMS Founder & CEO, Selected as a Finalist for 2011 Business Person of the Year Award
4. Selected Value Therapeutics Exercises Right to Develop and Commercialize ENMD-2076 in China
5. Apricoxib Prolongs Time-to-Progression and Overall Survival in Biomarker-Selected NSCLC Patients
6. Beaumont Health System One of 14 Selected for National High Value Health Care Collaborative for High Quality Care at Lower Cost
7. Five Californians Selected as Breakaway from Cancer® Champions to be Honored During Amgen Tour of California
8. GenerationOne Selected by Cincinnati Childrens Hospital Medical Center for Mobile Health Pilot with Teen Asthmatics
9. ZINO Society Fund Investors Selected VacuPractor
10. Hanmi Pharmaceuticals to Acquire the Rights for a Promising Phase II Anti-cancer Src Kinase/Pretubulin Dual Inhibitor from Kinex Pharmaceuticals, in Selected Asian Territories
11. Digital Assent CEO Selected as Finalist for 2011 Southeast Entrepreneur Awards
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/8/2016)... , Dec. 8, 2016  Eli Lilly and ... results of its phase 3 EXPEDITION3 trial at the ... meeting. As previously disclosed, solanezumab did not meet the ... of solanezumab initiated in people with mild dementia due ... regulatory submissions for solanezumab for the treatment of mild ...
(Date:12/8/2016)... de dezembro de 2016  A Mederi Therapeutics Inc . anunciou aprovação ... não cirúrgico para a doença do refluxo gastroesofágico (DRGE). Foto -  ... ... Live Stretta procedure performed and broadcast during the Chinese ... Union Hospital , ...
(Date:12/8/2016)... Pa. , Dec. 8, 2016  Pennsylvania ... Secretary of Drug and Alcohol Programs Gary ... and insomnia medications, known as benzodiazepines, developed with ... "Benzodiazepines are medications that are frequently prescribed ... when they are used with opioid pain medications, ...
Breaking Medicine Technology:
(Date:12/9/2016)... ... December 09, 2016 , ... Sober College, ... with the grand opening of the Sober College Robert Pfeifer Memorial Learning Center ... December 2-3, and was attended by an overwhelming amount of alumni, family, colleagues ...
(Date:12/9/2016)... , ... December 09, 2016 , ... "I had a ... inventor from Winchester, Va. "I thought that if the nebulizer had a more child-friendly ... than fearing them." , He developed the patent-pending NEBY to avoid the need to ...
(Date:12/8/2016)... , ... December 08, 2016 , ... ... Franchising Company LLC, announced the first national #QuackGivesBack campaign which supported local ... “This was our first franchise-wide Quack Gives Back initiative, and we’re ...
(Date:12/8/2016)... ... December 08, 2016 , ... With the increasing demand for dental implants, the ... (WIYM) campaign to inform dentists and patients about the safety issues related to dental ... market in the U.S. is projected to reach $6.4 billion in 2018 with more ...
(Date:12/8/2016)... ... 2016 , ... Catalent Pharma Solutions, the leading global provider ... products, today announced that it had joined the Pharmaceutical Supply Chain Initiative (PSCI). ... unite pharmaceutical and healthcare companies that share a vision of better, social, environmental ...
Breaking Medicine News(10 mins):